Binder Groesswang, working with Hengeler Mueller and Baer & Karrer, has advised private equity investor Trill Impact on its partnership with cleanroom plastics manufacturer TT Medic.
According to Binder Groesswang, the TT Medic Group specializes in the development, production, and cleanroom processing of plastic components for the life science industry. The company, with locations in Germany, Austria, and Switzerland, employs more than 150 people and, as a contract development and manufacturing organization, covers almost the entire value chain of cleanroom processing of polymer components.
Founded in 2019, Trill Impact is an investor with assets under management of around EUR 1.2 billion in private equity, ventures, and microfinance investment strategies.
The Binder Groesswang team included Partners Philipp Kapl, Regina Kroell, and Clemens Willvonseder, Counsels Sabine Apfl-Trampeter and Hellmut Buchroithner, Senior Associates Mona Holzgruber, David Roetzer, Christoph Raab, and Anian Gruber, and Associates Florian Hoellebauer, Christopher Marchel, Magdalena Schachinger, Tobias Haralter, Florian Defrancesco, Armin Nimmrichter, Dario Schmelz, and Manuela Wenger.
